These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 8903369
1. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okuno T. Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369 [Abstract] [Full Text] [Related]
2. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
4. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Rémiré J, Soussy CJ, Dhumeaux D. J Med Virol; 1998 Apr 01; 54(4):256-64. PubMed ID: 9557291 [Abstract] [Full Text] [Related]
5. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, Kamada T. Hepatology; 1994 Nov 01; 20(5):1121-30. PubMed ID: 7523271 [Abstract] [Full Text] [Related]
8. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications. Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J. Rev Esp Enferm Dig; 1997 Jul 01; 89(7):531-50. PubMed ID: 9265839 [Abstract] [Full Text] [Related]
9. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug 01; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
10. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. N Engl J Med; 1996 Jan 11; 334(2):77-81. PubMed ID: 8531962 [Abstract] [Full Text] [Related]
11. Patterns of hepatitis C viremia in patients receiving hemodialysis. Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB. Am J Gastroenterol; 1997 Jan 11; 92(1):73-8. PubMed ID: 8995941 [Abstract] [Full Text] [Related]
12. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. González-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JY. J Med Virol; 1996 Jul 11; 49(3):242-7. PubMed ID: 8818972 [Abstract] [Full Text] [Related]
13. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Zeuzem S, Lee JH, Roth WK. Hepatology; 1997 Mar 11; 25(3):740-4. PubMed ID: 9049228 [Abstract] [Full Text] [Related]
14. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E. Ital J Gastroenterol Hepatol; 1997 Jun 11; 29(3):255-61. PubMed ID: 9646218 [Abstract] [Full Text] [Related]
15. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M. J Med Virol; 1996 Apr 11; 48(4):354-9. PubMed ID: 8699168 [Abstract] [Full Text] [Related]
16. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H. Hepatology; 1997 Mar 11; 25(3):745-9. PubMed ID: 9049229 [Abstract] [Full Text] [Related]
17. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C. Berenguer M, Olaso V, Córdoba J, Gobernado M, Carrasco D, Berenguer J. Eur J Gastroenterol Hepatol; 1995 Sep 11; 7(9):899-903. PubMed ID: 8574725 [Abstract] [Full Text] [Related]
18. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatology; 1995 Aug 11; 22(2):418-25. PubMed ID: 7543433 [Abstract] [Full Text] [Related]
19. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy]. Tang X, Qian K, Yuan X, Johnson YN. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 11; 16(2):128-31. PubMed ID: 12196822 [Abstract] [Full Text] [Related]
20. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy. Yeh BI, Han KH, Oh SH, Kim HS, Hong SH, Oh SH, Kim YS. J Med Virol; 1996 Jun 11; 49(2):95-102. PubMed ID: 8991943 [Abstract] [Full Text] [Related] Page: [Next] [New Search]